Literature DB >> 27086247

DSM-5 section III personality traits and section II personality disorders in a Flemish community sample.

Tim Bastiaens1, Dirk Smits2, Marc De Hert3, Dominique Vanwalleghem4, Laurence Claes5.   

Abstract

The Personality Inventory for DSM-5 (PID-5; Krueger et al., 2012) is a dimensional self-report questionnaire designed to measure personality pathology according to the criterion B of the DSM-5 Section III personality model. In the current issue of DSM, this dimensional Section III personality model co-exists with the Section II categorical personality model derived from DSM-IV-TR. Therefore, investigation of the inter-relatedness of both models across populations and languages is warranted. In this study, we first examined the factor structure and reliability of the PID-5 in a Flemish community sample (N=509) by means of exploratory structural equation modeling and alpha coefficients. Next, we investigated the predictive ability of section III personality traits in relation to section II personality disorders through correlations and stepwise regression analyses. Results revealed a five factor solution for the PID-5, with adequate reliability of the facet scales. The variance in Section II personality disorders could be predicted by their theoretically comprising Section III personality traits, but additional Section III personality traits augmented this prediction. Based on current results, we discuss the Section II personality disorder conceptualization and the Section III personality disorder operationalization.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Community sample; Convergent validity; Cross-walk; Divergent validity; PID-5; Reliability

Mesh:

Year:  2016        PMID: 27086247     DOI: 10.1016/j.psychres.2016.02.056

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

Review 1.  A Brief but Comprehensive Review of Research on the Alternative DSM-5 Model for Personality Disorders.

Authors:  Johannes Zimmermann; André Kerber; Katharina Rek; Christopher J Hopwood; Robert F Krueger
Journal:  Curr Psychiatry Rep       Date:  2019-08-13       Impact factor: 5.285

Review 2.  The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, alternative model conceptualization of borderline personality disorder: A review of the evidence.

Authors:  Salome Vanwoerden; Stephanie D Stepp
Journal:  Personal Disord       Date:  2022-07

3.  The Personality Inventory for DSM-5 Short Form (PID-5-SF): psychometric properties and association with big five traits and pathological beliefs in a Norwegian population.

Authors:  Jens C Thimm; Stian Jordan; Bo Bach
Journal:  BMC Psychol       Date:  2016-12-07

4.  Personality Inventory for DSM-5 in China: Evaluation of DSM-5 and ICD-11 Trait Structure and Continuity With Personality Disorder Types.

Authors:  Shulin Fang; Zirong Ouyang; Panwen Zhang; Jiayue He; Lejia Fan; Xingwei Luo; Jianghua Zhang; Yan Xiong; Fusheng Luo; Xiaosheng Wang; Shuqiao Yao; Xiang Wang
Journal:  Front Psychiatry       Date:  2021-03-26       Impact factor: 4.157

5.  Psychometric study of the brazilian version of the personality inventory for DSM-5-paper-and-pencil version.

Authors:  Ana Maria Barchi-Ferreira; Flávia de Lima Osório
Journal:  Front Psychiatry       Date:  2022-09-13       Impact factor: 5.435

6.  More habitual physical activity is linked to the use of specific, more adaptive cognitive reappraisal strategies in dealing with stressful events.

Authors:  Corinna M Perchtold-Stefan; Andreas Fink; Christian Rominger; Elisabeth M Weiss; Ilona Papousek
Journal:  Stress Health       Date:  2020-02-09       Impact factor: 3.519

7.  Humorous cognitive reappraisal: More benign humour and less "dark" humour is affiliated with more adaptive cognitive reappraisal strategies.

Authors:  Corinna M Perchtold; Elisabeth M Weiss; Christian Rominger; Kurt Feyaerts; Willibald Ruch; Andreas Fink; Ilona Papousek
Journal:  PLoS One       Date:  2019-01-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.